TY - JOUR
T1 - Involvement of serum dehydroepiandrosterone sulfate in erythropoietic activity
AU - Harada, Ko
AU - Hanayama, Yoshihisa
AU - Obika, Mikako
AU - Itoshima, Koichi
AU - Okada, Ken
AU - Otsuka, Fumio
N1 - Funding Information:
The authors are sincerely grateful to all of the clinical staff in the Department of General Medicine who contributed to the present work.
Publisher Copyright:
© 2019 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2021
Y1 - 2021
N2 - Purpose: The aim of the present study was to determine how age-related decreases in serum dehydroepiandrosterone sulfate (DHEAS) levels affect various physiological processes. Methods: We retrospectively reviewed the medical records of patients in whom serum DHEAS levels were measured in our department and assessed the relationships between serum DHEAS levels and various patient characteristics. Results: Among the 149 patients included in our analysis (mean age: 52.7 ± 17.6 years, range: 15–84 years), 54 (36.2%) were men. Serum DHEAS levels inversely correlated with age in men (R = −0.810, p <.01) and to a lesser extent in women (R = −0.391, p <.01). Of note, there were significant positive associations between DHEAS levels and hemoglobin (R = 0.317, p ≤.01) and hematocrit (R = 0.324, p ≤.01) levels, which were observed in men, but not in women. Conclusions: Our study suggests that reduced DHEAS secretion inhibits erythropoietic activity in aging men, perhaps owing to the erythropoietic androgenic actions of DHEAS. Importantly, it suggests that the age-associated decline in DHEAS secretion might decrease erythropoietic activity in aging men. It is also possible that the adrenal cortex, the source of DHEAS, is dysfunctional in anemic men.
AB - Purpose: The aim of the present study was to determine how age-related decreases in serum dehydroepiandrosterone sulfate (DHEAS) levels affect various physiological processes. Methods: We retrospectively reviewed the medical records of patients in whom serum DHEAS levels were measured in our department and assessed the relationships between serum DHEAS levels and various patient characteristics. Results: Among the 149 patients included in our analysis (mean age: 52.7 ± 17.6 years, range: 15–84 years), 54 (36.2%) were men. Serum DHEAS levels inversely correlated with age in men (R = −0.810, p <.01) and to a lesser extent in women (R = −0.391, p <.01). Of note, there were significant positive associations between DHEAS levels and hemoglobin (R = 0.317, p ≤.01) and hematocrit (R = 0.324, p ≤.01) levels, which were observed in men, but not in women. Conclusions: Our study suggests that reduced DHEAS secretion inhibits erythropoietic activity in aging men, perhaps owing to the erythropoietic androgenic actions of DHEAS. Importantly, it suggests that the age-associated decline in DHEAS secretion might decrease erythropoietic activity in aging men. It is also possible that the adrenal cortex, the source of DHEAS, is dysfunctional in anemic men.
KW - Adrenopause
KW - anemia
KW - dehydroepiandrosterone sulfate
KW - erythropoiesis
UR - http://www.scopus.com/inward/record.url?scp=85063275602&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063275602&partnerID=8YFLogxK
U2 - 10.1080/13685538.2019.1592151
DO - 10.1080/13685538.2019.1592151
M3 - Article
C2 - 30905228
AN - SCOPUS:85063275602
SN - 1368-5538
VL - 23
SP - 756
EP - 763
JO - Aging Male
JF - Aging Male
IS - 5
ER -